New firm foregoes industry funding

Lighthouse Learning is offering to produce CME content that is free of commercial support.

Started by a Harvard neurologist and two executives, the firm will exclusively license its content nationwide to medical societies, insurers and meetings companies.

“In the big picture, any steps that CME providers can take to alter the perception of commercial bias in CME will serve us all well,” Jon Leibowitz, president and CEO of the new organization, told MM&M.

Its funding model is not new, though, said Dr. Murray Kopelow, executive director of the Accreditation Council for CME: 943—or 42% of the 2,225 ACCME-accredited providers submitting data for the 2009 ACCME annual data report—took no commercial support for their educational programs. It's not known whether any of them operate on a national scale, as Lighthouse intends to do.

Lighthouse is aiming for provisional ACCME accreditation by next year and hopes to conduct activities in 2011 with another organization serving as joint sponsor.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.